
The World Health Organisation (WHO) is expected to trigger a Public Health Emergency over the Wuhan coronavirus outbreak, meaning it …

AstraZeneca’s Tagrisso (osimertinib) has been knocked back for routine use on the NHS in England and Wales by the drug …

Novartis has inaugurated its new legal entity in Vietnam, Novartis Vietnam Co Ltd, and has become one of the first …

The European Commission has awarded conditional marketing approval to Roche’s Polivy (polatuzumab vedotin), it has been revealed.

NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in …

Jazz Pharmaceuticals has secured approval from the European Commission for Sunosi (solriamfetol), it has emerged, as a therapy to improve …

A team at Cardiff University have discovered a new part of the human immune system that could be harnessed to …

The European Medicines Agency (EMA) has granted a licence for the use of Mayzent (siponimod) in the treatment of certain …

Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019 compared …

Following the recommendation of the tablet formulation of the drug for use on the NHS in England and Wales, news …

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …

A judge in Philadelphia has reduced the amount of damages Johnson & Johnson was ordered to pay by a jury …

UK drug watchdog NICE has turned down Bayer’s Vitrakvi (larotrectinib) as a tumour-agnostic treatment solution on the NHS after it …

The viral pneumonia outbreak that began in Wuhan China can spread between person to person, according to health experts at …

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs …

Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …

Japan’s Ministry of Health, Labour and Welfare (MHLW) has awarded marketing approval to ViiV Healthcare, a subsidiary of GSK, for …

A UK wide trial called MND-SMART has invited hundreds of people with motor neurone disease (MND) to participate. It will …

A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …

Novo Nordisk has seen label expansions approved from the FDA for both its glucagon-like peptide-1 (GLP-1) analogue injection Ozempic (once-weekly …